COVID-19: Oxford Vaccine Trials Delayed Due to Safety Approvals

The clinical trials for the COVID-19 vaccine candidate being jointly developed by AstraZeneca and the University of Oxford have been delayed by at least a week. According to a Times of India report, the trials were earlier expected to begin by the first week of September at PGIMER (The Post Graduate Institute of Medical Education and Research) in Chandigarh.

The delay has been encountered due to a pending safety approval from Data Safety and Monitoring Board (DSMB) for the first hundred candidates selected to undergo the trials, the institute told IANS.